Science Intelligence and InfoPros

Little things about Scientitic Watch and Information Professionnals

Pharma and SM: one minute it’s on,…

leave a comment »

the next it’s off.

Old familiar worries” are “about adverse event and off-label discussions compounded by the delay of FDA guidelines”.

companies that abandon Facebook will miss out on a “powerful community that is already woven into billions of lives whose voices want and need to be heard“.

Business cases:

  • Sanofi’s VOICES Facebook page
  • Bayer’s tweets mistakes
  • Roche SM guideline
  • J&J Children with diabetes community
  • AstraZeneca Twitter discussion
Read more on:
Houston, Peter. Pharma and social media: time to become better friends. Pharmaceutical Executive, Digital edition, September 2011. pp.68-72

Written by hbasset

October 6, 2011 at 7:38 pm

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: